EASTMAN CHEMICAL CO
EMN · Materials · $15.2B mkt cap · FY2025 filings · No moat ·
Doesn't clear the bar
The five investor questions
2007–2025: revenue 6830000000.00 to 8752000000.00, increasing; diluted EPS 3.84 to 4.10, increasing.
Median gross margin 24.0% over 10y, very stable.
Median ROIC 11.7%, above the 12% hurdle in 50% of years.
Insufficient leverage/coverage inputs to score the balance sheet.
Owner earnings -6.3%/yr, share count growing (dilution).
The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
Price vs. owner-earnings value range
- Owner earnings (normalized)
- $857.0M
- Value range / share
- $42.52–$45.83
- Conservative high estimate / share
- $45.83
- Recent price
- $68.08
- Price vs. high estimate
- 49% above high estimate
Conservative range under moat-index@2.0.0: low end 11.1×, high end capped at 18×; 9% discount rate; high-end growth 1% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.
20 years of fundamentals
The business, in plain English
EASTMAN CHEMICAL CO booked $8.8B of revenue in FY2025 in the Materials sector and kept 21.1% of it as gross profit — a moderate-margin business by that measure. After every other cost, 5.4% of each revenue dollar reached the bottom line.
Across the filed record, revenue grew from $6.8B (FY2007) to $8.8B (FY2025) — about 1.4% a year compounded over 18 years.
It earned 13.0% on invested capital in FY2017, with a median of 20.3% across 11 filed years. The Returns on Capital filter above scores it 46/100.
The balance sheet carried $4.8B of total debt in FY2025 against $474.0M of owner earnings — roughly 10.1 years of owner earnings to retire it all.
The share count rose 18.5% between FY2008 and FY2025 — existing owners have been diluted over the record. Capital Discipline scores it 14/100.
This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.
Gaps in a line mean that item isn’t in EMN’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.
Moat Score history
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
- Methodology upgraded moat-index@1.2.0tomoat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Track record
How EASTMAN CHEMICAL CO’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.
How to read this: each dot is what the engine would have scored EMN on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.
Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The price path is a total-return (dividends reinvested) index built from the same data the forward returns use; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.
What followed, in the years it rated Wide
In the reconstructed history shown, EMN did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.
Materials context
#176 of 304 scored Materials companies, ranked by Moat Score.
Nearest peers by Moat Score
- #174BLGO BIOLARGO, INC.37.3 out of 100, No moatNo moat
- #175PURE PURE Bioscience, Inc.37.1 out of 100, No moatNo moat
- #177CPSH CPS TECHNOLOGIES CORP.36.8 out of 100, No moatNo moat
- #178JHX JAMES HARDIE INDUSTRIES PLC36.8 out of 100, No moatNo moat
Compare EMN with its nearest peers →All Materials companies on the Index →
Common questions about EMN
- Does EASTMAN CHEMICAL CO have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores EASTMAN CHEMICAL CO (EMN) 36.9 out of 100 — below the Shallow-moat bar, so no moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 48, pricing power 39, returns on capital 46, balance-sheet safety not measurable from the filings, capital discipline 14.
- Is EMN trading below the conservative owner-earnings estimate?
- The owner-earnings value range is $42.52–$45.83 per share. It capitalizes normalized owner earnings at a 9% rate; the low end assumes 0% growth and the high end uses 1% growth, capped at 4% and 18×. Versus a recent price of $68.08, that is 49% above high estimate relative to the high estimate. This is a conservative educational estimate from primary SEC filings, not intrinsic value as a fact or investment advice.
- How has EMN's Moat Score changed over time?
- The record logs 9 readings since Jul 17, 2026; the latest reads 36.9 out of 100 (no moat). No tier changes on record yet. (A methodology upgrade on Jul 20, 2026 re-based the score; readings across engine versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.